[The efficacy of 6 months' chemotherapy of newly diagnosed patients with pulmonary tuberculosis]. 1990

Iu Gamperis, and D Gaĭdamonene, and M Dimbelene, and L Pavlitska, and Z Nevirovska

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

Iu Gamperis, and D Gaĭdamonene, and M Dimbelene, and L Pavlitska, and Z Nevirovska
August 2018, Advances in respiratory medicine,
Iu Gamperis, and D Gaĭdamonene, and M Dimbelene, and L Pavlitska, and Z Nevirovska
January 1985, Problemy tuberkuleza,
Iu Gamperis, and D Gaĭdamonene, and M Dimbelene, and L Pavlitska, and Z Nevirovska
January 2004, Problemy tuberkuleza i boleznei legkikh,
Iu Gamperis, and D Gaĭdamonene, and M Dimbelene, and L Pavlitska, and Z Nevirovska
January 2015, Annals of global health,
Iu Gamperis, and D Gaĭdamonene, and M Dimbelene, and L Pavlitska, and Z Nevirovska
November 1996, American journal of respiratory and critical care medicine,
Iu Gamperis, and D Gaĭdamonene, and M Dimbelene, and L Pavlitska, and Z Nevirovska
January 2022, Pakistan journal of medical sciences,
Iu Gamperis, and D Gaĭdamonene, and M Dimbelene, and L Pavlitska, and Z Nevirovska
January 1991, Problemy tuberkuleza,
Iu Gamperis, and D Gaĭdamonene, and M Dimbelene, and L Pavlitska, and Z Nevirovska
October 1984, Problemy tuberkuleza,
Iu Gamperis, and D Gaĭdamonene, and M Dimbelene, and L Pavlitska, and Z Nevirovska
January 1974, Problemy tuberkuleza,
Iu Gamperis, and D Gaĭdamonene, and M Dimbelene, and L Pavlitska, and Z Nevirovska
January 2019, International journal of mycobacteriology,
Copied contents to your clipboard!